OTEurope

Macular disease accounts for nearly 10% of world's blindness

Jul 11, 2014

In 2010, 2.1 million people were blind and 6 million people were visually impaired because of macular diseases other than diabetic maculopathy, according to a meta-analysis conducted by members of the Vision Loss Expert Group of the Global Burden of Disease Study Group.

Related Videos

Fluid dynamics in wet macular degeneration: How fluid type affects visual acuity

EURETINA leadership discusses what to expect at the 2022 Congress, outlines Women in Retina programme

Paediatric eyes repair better with scleral buckling, adults need vitrectomy only for giant retinal tear-related detachments

Related Content

Pearls for management of Pseudomonas scleritis

Federal investment and regulatory benefits draw biotech firms to Switzerland

Preservative-free latanoprost as effective as BAK-preserved latanoprost

UK patients with vision loss confused by ‘disjointed’ benefits registration system

Late spring heatwave poses vision risk to populations across Europe

Stating the facts about combination myopia management treatments

Pearls for management of Pseudomonas scleritis

Federal investment and regulatory benefits draw biotech firms to Switzerland

Preservative-free latanoprost as effective as BAK-preserved latanoprost

UK patients with vision loss confused by ‘disjointed’ benefits registration system

Late spring heatwave poses vision risk to populations across Europe

Stating the facts about combination myopia management treatments

Pearls for management of Pseudomonas scleritis

Federal investment and regulatory benefits draw biotech firms to Switzerland

Preservative-free latanoprost as effective as BAK-preserved latanoprost

UK patients with vision loss confused by ‘disjointed’ benefits registration system

Late spring heatwave poses vision risk to populations across Europe

Stating the facts about combination myopia management treatments

Related Content

Pearls for management of Pseudomonas scleritis

Pearls for management of Pseudomonas scleritis

Dr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis

An airport departure board shows a flight to Geneva is boarding. Image credit: ©WD Stockphotos – stock.adobe.com

Federal investment and regulatory benefits draw biotech firms to Switzerland

The country is home to 20% of biotechs headquartered in Europe.

Preservative-free latanoprost as effective as BAK-preserved latanoprost

Preservative-free latanoprost as effective as BAK-preserved latanoprost

Therapeutic has fewer adverse effects in patients with POAG and OHT, study results show

UK patients with vision loss confused by ‘disjointed’ benefits registration system

UK patients with vision loss confused by ‘disjointed’ benefits registration system

Accessibility obstacles could prevent those with sight loss from receiving support and care.

Late spring heatwave poses vision risk to populations across Europe

Late spring heatwave poses vision risk to populations across Europe

What ophthalmologists want patients to know ahead of UK bank holiday.

Stating the facts about combination myopia management treatments

Stating the facts about combination myopia management treatments

Growing evidence supports dual therapy to slow progression.

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.